Live Poll Results — Which pharmaceutical company's controversial 2018 rebranding of a struggling med
See real-time poll results. Powered by AIPolls.Net.
Pharmaceutical Branding Breakthrough
In the competitive world of medical retail, pharmaceutical companies invest millions in branding to distinguish their products. Some branding decisions have significantly impacted market perception and sales. This poll tests your knowledge about a groundbreaking rebranding strategy that transformed a medication's market position despite facing initial skepticism from industry experts.
Which pharmaceutical company's controversial 2018 rebranding of a struggling medication included changing its packaging color scheme from blue to high-contrast orange, resulting in a 78% increase in patient recognition and adherence?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Novartis with their hypertension medication Diovan', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'AstraZeneca with their respiratory inhaler Symbicort', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Pfizer with their anticoagulant Eliquis', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Eli Lilly with their diabetes medication Trulicity', 'is_correct': False} | 0 | 0% |